Objectives To address concerns related to the safety profile of both Food and Drug
Administration (FDA)–approved and non–FDA-approved intranasal corticosteroid (INCS) …

Objective Intranasal corticosteroids (INCSs) are widely utilized for the treatment of allergic
rhinitis. Epistaxis is a known adverse effect of INCSs, but it is not known if the risk of epistaxis …

Methods: The study was conducted by three authors, namely the writing support team. The
support team made the study plan, determined the writing instructions, chose the subgroups …

Objective To review what is known about the importance of shared decision making (SDM)
in allergic rhinitis. Data Sources MEDLINE and PubMed database searches for SDM, patient …

Allergic rhinitis (AR) is a disease with a significant global burden, associated with many
comorbidities and quality-of-life issues. Overwhelming evidence shows that intranasal …

Background Sensory attributes of intranasal corticosteroids, such as rundown to the back of
the throat, may influence patient treatment preferences. This study compares the nasal …

Background Corticosteroid nasal sprays are the mainstay of treatment for allergic rhinitis.
These sprays have sensory attributes such as scent and/or odor, taste and aftertaste, and …

Allergic rhinitis (AR) affects at least 60 million people in the United States each year,
resulting in a major impact on patient quality of life, productivity, and direct and indirect costs …

Intranasal corticosteroids (INSs) have been effectively used for > 40 years for the
treatment of seasonal allergic rhinitis (SAR) and perennial AR (PAR). Following the Montreal …

目的探讨不同鼻腔冲洗温度对变应性鼻炎患者的临床效果. 方法采用随机数字法将200
例变应性鼻炎患者平均分为A, B 和C 3 组, 分别给予15, 25 和40℃ 生理盐水进行鼻腔冲洗 …